Charles River Laboratories International (CRL) Price/Sales Ratio

Price: $117.29
Market Cap: $5.76B
Avg Volume: 1.70M
Country: US
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Beta: 1.45
52W Range: $91.86-254.15
Website: Charles River Laboratories International

What is Charles River Laboratories International's Price/Sales Ratio?

  • Charles River Laboratories International's trailing twelve month (TTM) Price/Sales ratio is 1.42.
  • Charles River Laboratories International's annual Price/Sales ratio as of today is 2.36.
  • Charles River Laboratories International's quarterly Price/Sales ratio is 9.50.

What is the Price/Sales Ratio?

The Price/Sales ratio (P/S ratio) is a valuation metric that compares a company's stock price to its revenues. A lower P/S ratio may indicate that a stock is undervalued.

How is the Price/Sales Ratio calculated?

The Price/Sales ratio is calculated by dividing the company's market capitalization by its total sales or revenue. The formula is:

P/S Ratio = Market Capitalization / Total Sales (Revenue)

Related Metrics

Other important metrics to assess Charles River Laboratories International's financial health include:

  • P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
    • Annual: 429.84
    • Quarterly: -11.13
    • TTM: 489.67
  • P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
    • Annual: 2.76
    • Quarterly: 2.75
    • TTM: 1.73
  • P/C Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
    • Annual: 12.99
    • Quarterly: 59.74
    • TTM: 8.17
  • PEG Ratio (Price/Earnings to Growth Ratio) - measures the company's valuation considering its earnings growth:
    • Annual: -4.63
    • Quarterly: 0.03
    • TTM: -5.10

These metrics provide insights into Charles River Laboratories International's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual Price/Sales Ratio

2.36

Quarterly Price/Sales Ratio

9.50

TTM Price/Sales Ratio

1.42

Charles River Laboratories International Historical Price/Sales Ratio
6.006.005.005.004.004.003.003.002.002.001.001.000.000.00Price/Sales Ratio20162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical P/E Ratio
500.00500.00400.00400.00300.00300.00200.00200.00100.00100.000.000.00P/E Ratio20162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical P/B Ratio
8.008.006.006.004.004.002.002.000.000.00P/B Ratio20162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical P/C Ratio
30.0030.0024.0024.0018.0018.0012.0012.006.006.000.000.00P/C Ratio20162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical PEG Ratio
12.0012.008.008.004.004.000.000.00-4.00-4.00-8.00-8.00-12.00-12.00PEG Ratio20162016201720172018201820192019202020202021202120222022202320232024202420252025

Charles River Laboratories International Historical Financial Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.

Year Price/Sales Ratio P/E Ratio P/B Ratio P/C Ratio PEG Ratio
2024 2.36 429.84 2.76 12.99 -4.63
2023 2.93 25.52 3.37 17.71 -8.14
2022 2.78 22.77 3.72 17.87 0.98
2021 5.25 47.49 7.33 24.41 8.31
2020 4.27 34.24 5.90 22.82 0.81
2019 2.82 29.38 4.53 15.39 3.08
2018 2.36 23.66 4.07 12.14 0.29
2017 2.80 42.13 4.97 16.43 -2.01
2016 2.13 23.14 4.28 12.01 9.29
2015 2.73 24.94 5.08 13.00 1.38

Related Metrics

Explore detailed financial metrics and analysis for CRL.